Alzheimer's Club

NeuroTrax Corporation Establishes Board of Advisors Consisting of Leaders in Science and Business. Jeffrey L. Cummings of NIH accredited Alzheimer's Disease Center at UCLA to hold NeuroTrax Advisory Board Member Post

NEW YORK (7 September 2005) - NeuroTrax Corporation announced today the establishment of a board of industry experts. According to Ely Simon, CEO of NeuroTrax, "These opinion leaders represent decades of executive-level experience in our most critical focus areas. Especially notable is the rare combination of highly credible scientific credentials and business expertise among the Advisory Board members."

The NeuroTrax Board of Advisors is chaired by Howard Fillit, M.D., the founding Executive Director of the Institute for the Study of Aging, a biomedical venture philanthropy foundation advancing drug discovery for Alzheimer's disease. Dr. Fillit has over 25 years of experience in the Alzheimer's and cognitive aging field, and is currently clinical professor of geriatrics, medicine, and professor of neurobiology at The Mount Sinai School of Medicine. Jeffrey L. Cummings, M.D., a leading authority in the fields of aging and dementia, is author of the Neuropsychiatric Inventory. He is the founder and director of the UCLA Alzheimer's Disease Center and past president of the Behavioral Neurology Society and the American Neuropsychiatric Association. Dr. Cummings has authored over 400 peer-reviewed papers. Paula Tallal, Ph.D. is a founder of Scientific Learning Corporation (Nasdaq: SCIL) and a world-recognized authority on language-learning disabilities. A cognitive neuroscientist and a clinical psychologist, she is a founder of the Center for Molecular and Behavioral Neuroscience at Rutgers University. In 1996, Dr. Tallal co-founded the Scientific Learning Corporation, a neuroscience company dedicated to developing and delivering research-based, cognitive and educational programs, where she currently serves on the Board. Dan Dragalin, M.D. is Executive Vice President of Multiplan, Inc., where he has responsibility for development and maintenance of the MultiPlan PPO network, the largest in the US, comprised of 4,600 hospitals, 100,000 ancillary facilities and over 500,000 practitioners. Prior to joining MultiPlan, Dr. Dragalin held executive positions in One Health Plan, NY Life, HMO Blue, Towers Perrin, Prudential Insurance Company of America. Dr. Dragalin has served as the Health Insurance Association of America representative on the AMA's CPT-4 Editorial Panel, Board of Directors of the National Committee on Quality Assurance, and the Managed Care Task Force of the Joint Commission.

NeuroTrax Corporation developed Mindstreams(R), a sophisticated computerized assessment suite performed in the doctor's office to detect the early signs of Alzheimer's disease and cognitive impairment from neurological psychiatric disease and to track treatment effects.

For more information, call toll-free 888-208-8160 or visit http://www.neurotrax.com.

Source: NeuroTrax Corporation Web Site: http://www.neurotrax.com PRNewswire Press release (7 September 2005) [FullText]